Edward Feener

Chief Scientific Officer/Scientific co-Founder

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

S. Kent Dickeson

Vanderbilt University School of Medicine

UNITED STATES

View details

David Gailani

Vanderbilt University

UNITED STATES

View details

Edwin Antony

Professor

Saint Louis University

UNITED STATES

View details

ruby law

MONASH UNIVERSITY

AUSTRALIA

View details

Ulrich F.O. Luhmann

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Edward Feener

Research Interests

Explore related searches

Contact this professor

Articles (6)

Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease

Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema

A mechanism for hereditary angioedema caused by a methionine-379–to–lysine substitution in kininogens

A mechanism for hereditary angioedema caused by a lysine 311–to–glutamic acid substitution in plasminogen

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on‐demand treatment of hereditary angioedema

Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation

Collaborators (5)

S. Kent Dickeson

David Gailani

Edwin Antony

ruby law

Ulrich F.O. Luhmann

Make your next move.